Assignee
PREC GROUP LIMITED
IE·11 granted patents·11 pending applications·10 citations·filing 2017–2024
Top patents by PatentIndex Score
22 records- 0190US10813366B2Bifidobacterium longum NCIMB 41676PREC GROUP LIMITED·Filed 2020·Granted Oct 27, 2020·3 cites·25 claims
- 0289US11400123B2Combination product for prophylaxis and treatment of irritable bowel syndromePREC GROUP LIMITED·Filed 2019·Granted Aug 2, 2022·1 cites·18 claims
- 0388US11225641B2Probiotic Bifidobacterium strainPREC GROUP LIMITED·Filed 2020·Granted Jan 18, 2022·2 cites·18 claims
- 0486US11490643B2Lactobacillus casei for treating obesity and associated metabolic disordersPREC GROUP LIMITED·Filed 2021·Granted Nov 8, 2022·1 cites·20 claims
- 0583US11771723B2Bifidobacterium longum NCIMB 41676PREC GROUP LIMITED·Filed 2019·Granted Oct 3, 2023·2 cites·20 claims
- 0683US10689719B2Bifidobacterium longumPREC GROUP LIMITED·Filed 2017·Granted Jun 23, 2020·1 cites·3 claims
- 0780US2022387523A1Combination product for prophylaxis and treatment of irritable bowel syndromePREC GROUP LIMITED·Filed 2022·Application pending·0 cites
- 0878US2023210921A1Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infectionPREC GROUP LIMITED·Filed 2022·Application pending·0 cites
- 0975US12419920B2Bifidobacterium longum NCIMB 41676PREC GROUP LIMITED·Filed 2023·Granted Sep 23, 2025·0 cites·20 claims
- 1074US2023405061A1Combination product for prophylaxis and treatment of irritable bowel syndromePREC GROUP LIMITED·Filed 2023·Application pending·0 cites
- 1172US2022169976A1Probiotic bifidobacterium strainPREC GROUP LIMITED·Filed 2021·Application pending·0 cites
- 1268US2021163878A1Modulation of tissue fatty acid composition of a host by human gut bacteriaPREC GROUP LIMITED·Filed 2020·Application pending·0 cites
- 1364US2020377961A1Bifidobacterium longumPREC GROUP LIMITED·Filed 2020·Application pending·0 cites
- 1463US2025145941A1Lactobacillus reuteriPREC GROUP LIMITED·Filed 2024·Application pending·0 cites
- 1562US11590179B2Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infectionPREC GROUP LIMITED·Filed 2018·Granted Feb 28, 2023·0 cites·5 claims
- 1660US2021127695A1Bifidobacterium longum ncimb 41676PREC GROUP LIMITED·Filed 2020·Application pending·0 cites
- 1759US2020375204A1Bifidobacterium longum ncimb 41676PREC GROUP LIMITED·Filed 2019·Application pending·0 cites
- 1858US12180463B2Lactobacillus reuteriPREC GROUP LIMITED·Filed 2020·Granted Dec 31, 2024·0 cites·19 claims
- 1952US12589124B2Bifidobacterium longumPREC GROUP LIMITED·Filed 2021·Granted Mar 31, 2026·0 cites·12 claims
- 2048US11529381B2Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infectionPREC GROUP LIMITED·Filed 2018·Granted Dec 20, 2022·0 cites·9 claims
- 2141US2020289586A1Combination product for prophylaxis and treatment of irritable bowel syndromePREC GROUP LIMITED·Filed 2019·Application pending·0 cites
- 2240US2020289588A1Bifidobacterium longum ncimb 41676PREC GROUP LIMITED·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PREC GROUP LIMITED files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →